Will you have Visual field defect with Akineton - from FDA reports


Visual field defect is found among people who take Akineton, especially for people who are female, 60+ old , have been taking the drug for 1 - 2 years, also take medication Zyprexa, and have Bipolar i disorder. This study is created by eHealthMe based on reports of 4,934 people who have side effects when taking Akineton from FDA, and is updated regularly.

What's eHealthMe?

eHealthMe is a health data analysis company based in Mountain View, California. eHealthMe monitors and analyzes the outcomes of drugs and supplements that are currently on the market. The results are readily available to health care professionals and consumers.

eHealthMe has released original studies on market drugs and worked with leading universities and institutions such as IBM, London Health Science Centre, Mayo Clinic, Northwestern University and VA. eHealthMe studies have now been referenced in over 500 peer-reviewed medical publications.

How we gather our data?

Healthcare data is obtained from a number of sources including the Food and Drug Administration (FDA). This information is aggregated and used to produce personalized reports that patients can reference.

The information that eHealthMe collects includes:

  • Side effects (including severity and how people recover from them)
  • Associated conditions or symptoms
  • Drug effectiveness
  • Demographic data regarding drug use

How the study uses the data?

The study is based on biperiden hydrochloride (the active ingredients of Akineton) and Akineton (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Synonyms of Visual field defect are also considered in the study.

What is Akineton?

Akineton has active ingredients of biperiden hydrochloride. It is often used in parkinson's disease. (latest outcomes from Akineton 4,968 users)

What is Visual field defect?

Visual field defect has been reported by people with multiple sclerosis, high blood pressure, erection problems, depression, rheumatoid arthritis (latest reports from 6,259 Visual field defect patients).

How to use the study?

Patients can bring a copy of the report to their healthcare provider to ensure that all drug risks and benefits are fully discussed and understood. It is recommended that patients use the information presented as a part of a broader decision-making process.

On Mar, 14, 2019

4,934 people reported to have side effects when taking Akineton.
Among them, 8 people (0.16%) have Visual field defect

Number of reports submitted per year:

Could Akineton cause Visual field defect?

Time on Akineton when people have Visual field defect *:

  • < 1 month: 0.0 %
  • 1 - 6 months: 0.0 %
  • 6 - 12 months: 0.0 %
  • 1 - 2 years: 100 %
  • 2 - 5 years: 0.0 %
  • 5 - 10 years: 0.0 %
  • 10+ years: 0.0 %

Gender of people who have Visual field defect when taking Akineton *:

  • female: 87.5 %
  • male: 12.5 %

Age of people who have Visual field defect when taking Akineton *:

  • 0-1: 0.0 %
  • 2-9: 0.0 %
  • 10-19: 0.0 %
  • 20-29: 0.0 %
  • 30-39: 0.0 %
  • 40-49: 20 %
  • 50-59: 0.0 %
  • 60+: 80 %

Top conditions involved for these people *:

  1. Insomnia (sleeplessness): 2 people, 25.00%
  2. High Blood Pressure: 2 people, 25.00%
  3. Depression: 2 people, 25.00%
  4. Bipolar I Disorder (mood disorder that is characterized by at least one manic or mixed episode): 2 people, 25.00%
  5. Schizophrenia (a mental disorder characterized by a breakdown of thought processes): 1 person, 12.50%
  6. Multiple Sclerosis (a nervous system disease that affects your brain and spinal cord. it damages the myelin sheath): 1 person, 12.50%
  7. Angiodysplasia (small vascular malformation of the gut): 1 person, 12.50%
  8. Agitation (state of anxiety or nervous excitement): 1 person, 12.50%
  9. Adverse Event: 1 person, 12.50%
  10. Adverse Drug Reaction: 1 person, 12.50%

Top co-used drugs for these people *:

  1. Zyprexa: 4 people, 50.00%
  2. Halcion: 2 people, 25.00%
  3. Seroquel: 2 people, 25.00%
  4. Norvasc: 2 people, 25.00%
  5. Mirtazapine: 2 people, 25.00%
  6. Micardis: 2 people, 25.00%
  7. Fluvoxamine Maleate: 2 people, 25.00%
  8. Avonex: 1 person, 12.50%
  9. Clonazepam: 1 person, 12.50%
  10. Effexor: 1 person, 12.50%

Top other side effects for these people *:

  1. Asphyxia (a condition in which there is an extreme decrease in the concentration of oxygen in the body): 3 people, 37.50%
  2. Death: 3 people, 37.50%
  3. White Blood Cell Count Increased: 2 people, 25.00%
  4. Completed Suicide (act of taking one's own life): 2 people, 25.00%
  5. Gamma-Glutamyltransferase Increased: 2 people, 25.00%
  6. Fibrin D Dimer Increased: 2 people, 25.00%
  7. Vision Blurred: 2 people, 25.00%
  8. Face Oedema (swelling of face): 2 people, 25.00%
  9. Eyelid Oedema (eyelids are swollen and contain excessive fluid): 2 people, 25.00%
  10. Eosinophil Count Increased: 2 people, 25.00%

* Approximation only. Some reports may have incomplete information.

Do you have Visual field defect while taking Akineton?

You are not alone:

Related studies

Drugs that are associated with Visual field defect
Visual field defect (1,212 drugs)
Could your condition cause Visual field defect
Visual field defect (858 conditions)
Akineton side effects

Browse side effects by gender and age

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Akineton
a b c d e f g h i j k l m n o p q r s t u v w x y z
Compare Akineton with similar drugs

What would happen?

Predict new side effects and undetected conditions when you take Akineton and have Visual field defect

FDA reports used in this study

Recent updates

Recent general studies
Recent personal studies

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only, and has not been supported by scientific studies or clinical trials unless otherwise stated. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

You may report adverse side effects to the FDA at http://www.fda.gov/medwatch/ or 1-800-FDA-1088 (1-800-332-1088).

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.